CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Naurex
Naurex logo

Naurex

Naurex: A biopharmaceutical developer of NMDA receptor modulators for depression, acquired by Allergan.

Evanston, IL, US🇺🇸
Founded
2008
Overview
M & A
Compare
Fundraising
Employees

Naurex, Inc. was a clinical-stage biopharmaceutical company developing novel therapies for depression and other central nervous system disorders. Its lead programs were rapastinel (GLYX-13), a once-weekly intravenous NMDA receptor modulator for major depressive disorder, and NRX-1074 (apimostinel), a next-generation NMDA receptor modulator.

Allergan acquired Naurex for a $560 million upfront payment net of cash acquired, plus potential development and sales milestone payments, adding both antidepressant candidates to its mental health pipeline. The underlying Naurex research platform was spun out as Aptinyx, led by much of the former Naurex team.

Naurex - M & A Snapshot

Open M & A
  • Allergan

    Acquired Naurex • Undisclosed • Aug 31, 2015

Naurex - Quick Facts

Who are Naurex's competitors?

Companies similar to Naurex include Axsome Therapeutics, Aptinyx, Evecxia and CeNeRx Biopharma.

When was Naurex founded?

Naurex was founded in 2008.

Where is Naurex's headquarters located?

Naurex's headquarters is located in Evanston, IL, US.

How much disclosed funding has Naurex raised?

As of Aug 31, 2015, Naurex has disclosed funding of $162.1M (USD). Undisclosed round amounts are excluded.

Naurex - Classification

Ownership
  • Private
  • Venture-backed
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731

Naurex - Similar Companies

Axsome Therapeutics logo

Axsome Therapeutics

axsome.com

Aptinyx logo

Aptinyx

aptinyx.com

Evecxia logo

Evecxia

evecxia.com

CeNeRx Biopharma logo

CeNeRx Biopharma

cenerx.com

Kures logo

Kures

Nacuity Pharmaceuticals logo

Nacuity Pharmaceuticals

nacuity.com

Eumentis Therapeutics logo

Eumentis Therapeutics

Sonexa Therapeutics logo

Sonexa Therapeutics

Psy Therapeutics logo

Psy Therapeutics

psythx.com

Enalare Therapeutics logo

Enalare Therapeutics

enalare.com

Euthymics Bioscience logo

Euthymics Bioscience

Sage Therapeutics logo

Sage Therapeutics

sagerx.com

Reset Pharmaceuticals logo

Reset Pharmaceuticals

resetpharma.com

MindSet Rx logo

MindSet Rx

Natrogen Therapeutics logo

Natrogen Therapeutics

Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified